Brief: Advicenne Announces Positive Opinion From French Transparency Commission For Its Drug Sibnayal In dRTA

Advicenne SA

20/12/2021 06:03

Dec 20 (Reuters) - ADVICENNE SA  ADVIC.PA :
    * ADVICENNE ANNOUNCES POSITIVE OPINION FROM THE FRENCH
TRANSPARENCY COMMISSION (HAS) FOR ITS DRUG SIBNAYAL™ IN DRTA
    * SIBNAYAL™ ELIGIBLE FOR REIMBURSEMENT BY FRENCH PUBLIC
HEALTH
INSURANCE SYSTEM
    * ASMR IV: RECOGNITION OF CONTRIBUTION OF SIBNAYAL™IN
TREATMENT OF
DRTA
    * THIS DECISION MAKES SIBNAYAL™ ONLY SPECIALTY
PHARMACEUTICAL
PRODUCT REIMBURSED IN TREATMENT OF DRTA IN FRANCE

Source text for Eikon:  ID:nBw8lXPwYa 
Further company coverage:  ADVIC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))